rs786200902
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_203486.3(DLL3):c.618delC(p.Cys207fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000119 in 1,509,786 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000013 ( 0 hom. )
Consequence
DLL3
NM_203486.3 frameshift
NM_203486.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.671
Genes affected
DLL3 (HGNC:2909): (delta like canonical Notch ligand 3) This gene encodes a member of the delta protein ligand family. This family functions as Notch ligands that are characterized by a DSL domain, EGF repeats, and a transmembrane domain. Mutations in this gene cause autosomal recessive spondylocostal dysostosis 1. Two transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 19-39503019-GC-G is Pathogenic according to our data. Variant chr19-39503019-GC-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 6832.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=1, Pathogenic=3}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DLL3 | NM_203486.3 | c.618delC | p.Cys207fs | frameshift_variant | 4/9 | ENST00000356433.10 | NP_982353.1 | |
DLL3 | NM_016941.4 | c.618delC | p.Cys207fs | frameshift_variant | 4/8 | NP_058637.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DLL3 | ENST00000356433.10 | c.618delC | p.Cys207fs | frameshift_variant | 4/9 | 2 | NM_203486.3 | ENSP00000348810.4 | ||
DLL3 | ENST00000205143.4 | c.618delC | p.Cys207fs | frameshift_variant | 4/8 | 1 | ENSP00000205143.3 | |||
DLL3 | ENST00000600437.1 | n.698delC | non_coding_transcript_exon_variant | 4/6 | 1 | |||||
DLL3 | ENST00000596614.5 | c.409+2351delC | intron_variant | 2 | ENSP00000471688.1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152052Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
152052
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000189 AC: 2AN: 105622Hom.: 0 AF XY: 0.0000170 AC XY: 1AN XY: 58744
GnomAD3 exomes
AF:
AC:
2
AN:
105622
Hom.:
AF XY:
AC XY:
1
AN XY:
58744
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000125 AC: 17AN: 1357734Hom.: 0 Cov.: 33 AF XY: 0.00000747 AC XY: 5AN XY: 669742
GnomAD4 exome
AF:
AC:
17
AN:
1357734
Hom.:
Cov.:
33
AF XY:
AC XY:
5
AN XY:
669742
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152052Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74264
GnomAD4 genome
AF:
AC:
1
AN:
152052
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74264
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:4Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Spondylocostal dysostosis 1, autosomal recessive Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Sep 20, 2018 | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 01, 2003 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 30, 2023 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 6832). This premature translational stop signal has been observed in individual(s) with spondylocostal dysostosis (PMID: 12791036). This variant is present in population databases (rs760040233, gnomAD 0.005%). This sequence change creates a premature translational stop signal (p.Cys207Alafs*34) in the DLL3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DLL3 are known to be pathogenic (PMID: 12746394). - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2019 | - - |
DLL3-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | May 30, 2017 | The DLL3 c.618delC (p.Cys207AlafsTer34) variant results in a frameshift, and is predicted to result in premature termination of the protein. The p.Cys207AlafsTer34 variant has been reported in one study and is found in one spondylocostal dysostosis patient in a compound heterozygous state with another frameshift variant (Bonafé et al. 2003). The variant was absent from 50 controls and is reported at a frequency of 0.00005 in the Latino population of the Genome Aggregation Database based on a single allele and hence the variant is presumed to be rare. The p.Cys207AlafsTer34 variant is predicted to disrupt the DSL domain, impairing the ability to interact with the Notch receptor (Bonafé et al. 2003). Due to the potential impact of frameshift variants, the p.Cys207AlafsTer34 variant is classified as a variant of unknown significance but suspicious for pathogenicity for DLL3-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at